OpenAI Launches 3 Healthcare Products as 230 Million Weekly Users Fuel Push Into 18% U.S. Economy
Updated
Updated · Forbes · Jul 7
OpenAI Launches 3 Healthcare Products as 230 Million Weekly Users Fuel Push Into 18% U.S. Economy
3 articles · Updated · Forbes · Jul 7
Summary
Three new healthcare products in six months anchor OpenAI’s latest push, including a clinician-focused ChatGPT and waitlist-only ChatGPT Health that connects medical records and wellness apps.
230 million people globally already use ChatGPT for health advice each week, and OpenAI says healthcare is a key growth vertical as it seeks new revenue after a reported $39 billion net loss in 2025.
Eight major health systems, including Cedars-Sinai and HCA Healthcare, are already customers, while OpenAI says millions of clinicians use ChatGPT weekly and more than 260 physicians have helped refine its medical responses.
Safety remains a central obstacle: a February Nature Medicine study found ChatGPT Health missed hospital escalation in more than half of necessary cases, even as OpenAI disputed the methodology and said newer models perform better.
Healthcare’s scale—about 18% of the U.S. economy—makes it a critical test of whether OpenAI can turn broad consumer adoption into durable enterprise business against Anthropic, Google and specialized health-tech rivals.
As China's cheap AI models expand, can US open-source alternatives ever truly compete globally?
Should the US government take equity stakes in AI giants to secure its technological future?
If Beijing cuts access to its AI, could dozens of American startups collapse overnight?
OpenAI in Healthcare 2026: Strategic Expansion, Market Impact, and the Race for AI-Driven Patient Care
Overview
Over the past six months, OpenAI has made a major move into healthcare, targeting both enterprise clients like pharmaceutical companies and the growing consumer health market. This push comes as the AI healthcare market rapidly expands, with huge potential for AI to transform drug discovery, clinical trials, and patient care. Many critical areas, such as clinical trial design, still lack full AI integration, leaving significant untapped opportunities. OpenAI’s advanced solutions can analyze massive datasets, uncover hidden patterns, and speed up hypothesis testing, aiming to address urgent global health challenges like obesity and diabetes with faster, more effective therapies.